Literature DB >> 26150265

Editorial: Is It Time to End Surgeon-Industry Consulting?

Seth S Leopold1.   

Abstract

Mesh：

Year:  2015        PMID： 26150265      PMCID： PMC4523536          DOI： 10.1007/s11999-015-4434-3

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  9 in total

1.  Physician-industry relations. Part 1: individual physicians.

Authors:  Susan L Coyle
Journal:  Ann Intern Med       Date:  2002-03-05       Impact factor: 25.391

2.  Financial payments by orthopedic device makers to orthopedic surgeons.

Authors:  Jason M Hockenberry; Paula Weigel; Andrew Auerbach; Peter Cram
Journal:  Arch Intern Med       Date:  2011-10-24

3.  Doctors and drug companies.

Authors:  David Blumenthal
Journal:  N Engl J Med       Date:  2004-10-28       Impact factor: 91.245

4.  Orthopaedic surgeons and the medical device industry: the threat to scientific integrity and the public trust.

Authors:  Richard H Gelberman; David Samson; Sohail K Mirza; John J Callaghan; Vincent D Pellegrini
Journal:  J Bone Joint Surg Am       Date:  2010-03       Impact factor: 5.284

5.  Orthopaedic Surgeons Receive the Most Industry Payments to Physicians but Large Disparities are Seen in Sunshine Act Data.

Authors:  Andre M Samuel; Matthew L Webb; Adam M Lukasiewicz; Daniel D Bohl; Bryce A Basques; Glenn S Russo; Vinay K Rathi; Jonathan N Grauer
Journal:  Clin Orthop Relat Res       Date:  2015-06-19       Impact factor: 4.176

6.  US doctors earn speaking and consulting fees from drug companies that sponsor their research.

Authors:  Michael McCarthy
Journal:  BMJ       Date:  2014-03-27

7.  Do gifts from the pharmaceutical industry affect trust in physicians?

Authors:  Michael J Green; Rebecca Masters; Benjamin James; Bree Simmons; Erik Lehman
Journal:  Fam Med       Date:  2012-05       Impact factor: 1.756

8.  Physician attitudes toward industry: a view across the specialties.

Authors:  Deborah Korenstein; Salomeh Keyhani; Joseph S Ross
Journal:  Arch Surg       Date:  2010-06

Review 9.  Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.

Authors:  Geoffrey K Spurling; Peter R Mansfield; Brett D Montgomery; Joel Lexchin; Jenny Doust; Noordin Othman; Agnes I Vitry
Journal:  PLoS Med       Date:  2010-10-19       Impact factor: 11.069
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.